Sialic acid (SA)-modified selenium nanoparticles coated with a high blood–brain barrier permeability peptide-B6 peptide for potential use in Alzheimer’s diseaseTiantian Yin, Jie Liu, Xianbo Zhou et al.|Acta Biomaterialia|2015Cited by 193
Early Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease Using a Composite of MemTrax and Blood BiomarkersWei–Neng Chen, Zhong Pei, Cha Lin et al.|Journal of Alzheimer s Disease|2023Cited by 7
Predicting brain amyloid load with digital and blood-based biomarkersWei–Neng Chen, Zhong Pei, Xinchong Shi et al.|Alzheimer s Research & Therapy|2025Cited by 7